Pharmanex

Closed portfolio with a later-stage archive tilt

According to ClinicalTrials.gov-derived indexes, Pharmanex sits in the top decile of US sponsors by registered trial count (#1,049 of 15,751 sponsors by registered trial count).

13 total trials none currently recruiting 13 completed later-stage tilt top decile by trial count

Pharmanex: 13 sponsored US clinical trials, none currently recruiting.

Pharmanex sponsors 13 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 13 completed. 2 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 1 trials.

Top-decile sponsor footprint

Pharmanex ranks in the top decile of sponsors by registered trial count (#1,049 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Phase Distribution

PhaseTrial count
Phase 4 2

Therapeutic Areas

How the Pharmanex archive is shaped

13 indexed studies, none listed as recruiting (0% open); 13 completed (100%).

Phase mix: 2 late (III/IV) vs 0 early (I/II) (later-stage heavy).

Top condition: Healthy (1 trial), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.